Schedule 13D ownership disclosure

Nuo Therapeutics, Inc

Security class unavailable · CUSIP: 67059V100

Event date: 2016-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,750,000
Percent of class
67.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-16-000005
Form type
SC 13D
Filer
Boyalife Investment Fund I, Inc.
CIK
CIK 1683332
Filed
Sep 02, 2016
Reporting period
May 05, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub